Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vafa Shahabi
RecombinantListeriaVaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
Cancer Research
Cancer Research
Oncology
Related publications
Human Papillomavirus Type 16 Nucleoprotein E7 Is a Tumor Rejection Antigen.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Immunostimulatory Oligodeoxynucleotides Containing the CpG Motif Are Effective as Immune Adjuvants in Tumor Antigen Immunization
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
mSphere
Microbiology
Molecular Biology
Human Papillomavirus Type 16 E7 Oncoprotein mediatesCCNA1promoter Methylation
Cancer Science
Cancer Research
Medicine
Oncology
Abrogation of Growth Arrest Signals by Human Papillomavirus Type 16 E7 Is Mediated by Sequences Required for Transformation.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
The E7 Protein of Human Papillomavirus Type 16 Sensitizes Primary Human Keratinocytes to Apoptosis
Oncogene
Cancer Research
Genetics
Molecular Biology
Regulation of the Cdc25A Gene by the Human Papillomavirus Type 16 E7 Oncogene
Oncogene
Cancer Research
Genetics
Molecular Biology
Human Papillomavirus Type 16 E7 Up-Regulates AKT Activity Through the Retinoblastoma Protein
Cancer Research
Cancer Research
Oncology
The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7
Journal of Virology
Insect Science
Immunology
Microbiology
Virology